Wordt geladen...
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.
To establish a baseline for care and overall survival (OS) based upon contemporary first-line treatments prescribed in the era before the introduction of immune checkpoint inhibitors, for people with metastatic non-small cell lung cancer (NSCLC) without common actionable mutations.Using a nationally...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science (PLoS)
2017-01-01
|
| Reeks: | PLoS ONE |
| Online toegang: | http://europepmc.org/articles/PMC5482433?pdf=render |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|